Picture of Simulations Plus logo

SLP Simulations Plus Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Momentum

Relative Strength (%)
1m+8.85%
3m+14.54%
6m-2.44%
1yr-12.36%
Volume Change (%)
10d/3m+0.68%
Price vs... (%)
52w High-14.29%
50d MA+4.59%
200d MA+6.95%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)60.09
PEG Ratio (f)3.1
EPS Growth (f)24.06%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value5.1
Price to Tang. Book7.23
Price to Free Cashflow70.75
Price to Sales13.96
EV to EBITDA64.12

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital4.57%
Return on Equity6.16%
Operating Margin12.69%

Financial Summary

Year End 31st AugUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue$m33.9741.5946.4753.9159.5868.0676.1714.96%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+14.19+7.78-3.92+24.5-15.92+27.5+22.53n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Aug 202431st Aug 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Simulations Plus EPS forecast chart

Profile Summary

Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. The Company's segments include software and services. It offers 12 software products for pharmaceutical research and development: GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, MonolixSuite, ADMET Predictor and MedChem Designer. Its services include population pharmacokinetic and pharmacodynamic, quantitative systems pharmacology/quantitative systems toxicology, and physiologically based pharmacokinetic. The Company provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions supporting product approval. Its software and consulting services are provided to various industries, including biotechnology and cosmetics.

Directors

Last Annual
August 31st, 2023
Last Interim
February 29th, 2024
Incorporated
July 17th, 1996
Public Since
June 18th, 1997
No. of Shareholders
50
No. of Employees
192
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
19,984,945

SLP Share Price Performance

Upcoming Events for SLP

Dividend For SLP.OQ - 0.0600 USD

Q3 2024 Simulations Plus Inc Earnings Release

Similar to SLP

Picture of 10X Genomics logo

10X Genomics

us flag iconNASDAQ Global Select Market

Picture of Accuray logo

Accuray

us flag iconNASDAQ Global Select Market

Picture of Akoya Biosciences logo

Akoya Biosciences

us flag iconNASDAQ Global Select Market

Picture of Align Technology logo

Align Technology

us flag iconNASDAQ Global Select Market

Picture of Alphatec Holdings logo

Alphatec Holdings

us flag iconNASDAQ Global Select Market

FAQ